Antihypertensive drugs and brain function: mechanisms underlying therapeutically beneficial and harmful neuropsychiatric effects

C Carnovale, C Perrotta, S Baldelli… - Cardiovascular …, 2023 - academic.oup.com
A bidirectional relationship exists between hypertension and psychiatric disorders, including
unipolar and bipolar depression, anxiety, post-traumatic stress disorder (PTSD), psychosis …

Vascularizing the brain in vitro

A Aazmi, H Zhou, W Lv, M Yu, X Xu, H Yang, YS Zhang… - Iscience, 2022 - cell.com
The brain is arguably the most fascinating and complex organ in the human body.
Recreating the brain in vitro is an ambition restricted by our limited understanding of its …

Intrathecal pseudodelivery of drugs in the therapy of neurodegenerative diseases: rationale, basis and potential applications

MG Manuel, BI Tamba, M Leclere, M Mabrouk… - Pharmaceutics, 2023 - mdpi.com
Intrathecal pseudodelivery of drugs is a novel route to administer medications to treat
neurodegenerative diseases based on the CSF-sink therapeutic strategy by means of …

Blood–brain barrier transporters: a translational consideration for CNS delivery of neurotherapeutics

PT Ronaldson, TP Davis - Expert Opinion on Drug Delivery, 2024 - Taylor & Francis
Introduction Successful neuropharmacology requires optimization of CNS drug delivery and,
by extension, free drug concentrations at brain molecular targets. Detailed assessment of …

Anti-Inflammatory Activities of 8-Benzylaminoxanthines Showing High Adenosine A2A and Dual A1/A2A Receptor Affinity

M Załuski, D Łażewska, P Jaśko… - International Journal of …, 2023 - mdpi.com
Chronic inflammation plays an important role in the development of neurodegenerative
diseases, such as Parkinson's disease (PD). In the present study, we synthesized 25 novel …

In vitro models of the blood–cerebrospinal fluid barrier and their applications in the development and research of (Neuro) Pharmaceuticals

F Dabbagh, H Schroten, C Schwerk - Pharmaceutics, 2022 - mdpi.com
The pharmaceutical research sector has been facing the challenge of neurotherapeutics
development and its inherited high-risk and high-failure-rate nature for decades. This hurdle …

Chemotherapy in pediatric brain tumor and the challenge of the blood–brain barrier

JR Malik, AT Podany, P Khan, CL Shaffer… - Cancer …, 2023 - Wiley Online Library
Background Pediatric brain tumors (PBT) stand as the leading cause of cancer‐related
deaths in children. Chemoradiation protocols have improved survival rates, even for non …

[HTML][HTML] Mutated isocitrate dehydrogenase (mIDH) as target for PET imaging in gliomas

F Neumaier, BD Zlatopolskiy, B Neumaier - Molecules, 2023 - mdpi.com
Gliomas are the most common primary brain tumors in adults. A diffuse infiltrative growth
pattern and high resistance to therapy make them largely incurable, but there are significant …

[HTML][HTML] Revolutionizing Neurotherapeutics: Nanocarriers Unveiling the Potential of Phytochemicals in Alzheimer's Disease

AP Kamath, PG Nayak, J John, S Mutalik… - …, 2024 - Elsevier
Neurological disorders pose a huge worldwide challenge to the healthcare system,
necessitating innovative strategies for targeted drug delivery to the central nervous system …

Nanoparticles loaded with natural medicines for the treatment of Alzheimer's disease

N Liu, J Ruan, H Li, J Fu - Frontiers in Neuroscience, 2023 - frontiersin.org
Alzheimer's disease (AD) is a progressive neurodegenerative disease that disrupts cognitive
function and severely affects the quality of life. Existing drugs only improve cognitive function …